Our results show that in mRNA level, FGL2 is only expressed in CD16+ myeloid cells in gliomas, a subpopulation mainly responsible for phagocytosis, antigen processing, presentation, and activation of T-cells. Here, FGL2 is linked to central nervous system cancer.